Concentrated epidemics of HIV, HCV, and HBV among Afghan refugees

Journal of Infection

Volumn 61, Issue 5, 2010, Pages 434-437

  Khanani, Muhammad Rafiq ^a   Ansari, Amna S ^b   Khan, Saeed ^b   Somani, Mehreen ^b   Kazmi, Shahana Urooj ^c   Ali, Syed H ^b  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

^c UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; DRUG ABUSE; EPIDEMIC; FEMALE; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; MALE; PAKISTAN; REFUGEE; RISK FACTOR; SCHOOL CHILD; SEROPREVALENCE; SEXUAL BEHAVIOR; TRAVEL; VIRUS TRANSMISSION; VULNERABLE POPULATION;

ADULT; AFGHANISTAN; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PAKISTAN; QUESTIONNAIRES; REFUGEES; RISK FACTORS; YOUNG ADULT;

EID: 78149359538     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.08.009     Document Type: Letter

References (25)

1. Rajabali A., Moin O., Ansari A.S., Khanani M.R., Ali S.H. Communicable disease among displaced Afghans: refuge without shelter. Nat Rev Microbiol 2009, 7(8):609-614.
2. Connolly M.A., Gayer M., Ryan M.J., Salama P., Spiegel P., Heymann D.L. Communicable diseases in complex emergencies: impact and challenges. Lancet 2004, 364(9449):1974-1983.
3. Beckwith C.G., DeLong A.K., Desjardins S.F., Gillani F., Bazerman L., Mitty J.A., et al. HIV infection in refugees: a case-control analysis of refugees in Rhode Island. Int J Infect Dis 2009, 13(2):186-192.
4. Surveillance Data. Sindh AIDS Control Program. In: Government of Sindh Pakistan, editor. 2004.
5. Shah S.A., Altaf A., Mujeeb S.A., Memon A. An outbreak of HIV infection among injection drug users in a small town in Pakistan: potential for national implications. Int J STD AIDS 2004, 15(3):209.
6. WHO/UNAIDS/UNICEF. Epidemiological Fact Sheet on HIV and AIDS Core data on epidemiology and response Pakistan. 2008; Update.
7. Ali S.A., Donahue R.M., Qureshi H., Vermund S.H. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis 2009, 13(1):9-19.
8. Todd C.S., Abed A.M., Strathdee S.A., Scott P.T., Botros B.A., Safi N., et al. HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis 2007, 13(9):1327-1331.
9. Todd C.S., Nasir A., Stanekzai M.R., Bautista C.T., Botros B.A., Scott P.T., et al. HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities. AIDS 2010, 24(Suppl. 2):S69-S75.
10. Todd C.S., Ahmadzai M., Atiqzai F., Smith J.M., Miller S., Azfar P., et al. Prevalence and correlates of HIV, syphilis, and hepatitis knowledge among intrapartum patients and health care providers in Kabul, Afghanistan. AIDS Care 2009, 21(1):109-117.
11. Todd C.S., Ahmadzai M., Atiqzai F., Miller S., Smith J.M., Ghazanfar S.A., et al. Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul, Afghanistan. BMC Infect Dis 2008, 8:119.
12. UNGASS country progress report Afghanistan National AIDS Control Program http://data.unaids.org/pub/Report/2010/afghanistan_2010_country_progress_report_en.pdf.
13. Adoga M.P., Banwat E.B., Forbi J.C., Nimzing L., Pam C.R., Gyar S.D., et al. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries 2009, 3(7):539-547.
14. Khan S., Rai M.A., Khanani M.R., Khan M.N., Ali S.H. HIV-1 subtype A infection in a community of intravenous drug users in Pakistan. BMC Infect Dis 2006, 6:164.
15. Zafar T., Brahmbhatt H., Imam G., ul Hassan S., Strathdee S.A. HIV knowledge and risk behaviors among Pakistani and Afghani drug users in Quetta, Pakistan. J Acquir Immune Defic Syndr 2003, 32(4):394-398.
16. Shafiq M., Ali S.H. Sexually transmitted infections in Pakistan. Lancet Infect Dis 2006, 6(6):321-322.
17. Resurgence of wild poliovirus type 1 transmission and consequences of importation-21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep 2006, 55(6):145-150.
18. Kazmi J.H., Pandit K. Disease and dislocation: the impact of refugee movements on the geography of malaria in NWFP, Pakistan. Soc Sci Med 2001, 52(7):1043-1055.
19. Baqi S., Kayani N., Khan J.A. Epidemiology and clinical profile of HIV/AIDS in Pakistan. Trop Doct 1999, 29(3):144-148.
20. CDC Hepatitis C virus and HIV coinfection. IDU HIV Prevention [cited; Available from:. http://www.cdc.gov/IDU/hepatitis/hepc_and_hiv_co.pdf.
21. Dore G.J., Cooper D.A. The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses. Curr Opin Infect Dis 2001, 14(6):749-755.
22. Soriano V on behalf of the SMART-INSIGHT study group. Antiretroviral therapy re-initiation and HBV rebound among HIV-HBV coinfected patients following ART interruption in the SMART Study. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, February 2009. [Abstr. Q-111].
23. Todd C.S., Stibich M.A., Stanekzai M.R., Rasuli M.Z., Bayan S., Wardak S.R., et al. A qualitative assessment of injection drug use and harm reduction programmes in Kabul, Afghanistan: 2006-2007. Int J Drug Policy 2009, 20(2):111-120.
24. Altaf A., Shah S.A., Zaidi N.A., Memon A., Nadeem ur R., Wray N. High risk behaviors of injection drug users registered with harm reduction programme in Karachi, Pakistan. Harm Reduct J 2007, 4:7.
25. Emmanuel F., Fatima M. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed. Int J Drug Policy 2008, 19(Suppl. 1):S59-S64.